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Screening for affective and anxiety disorders in medical
patients: comparison of HADS, GHQ-12 and Brief-PHQ
Screening nach affektiven und Angststörungen bei Patienten in der
medizinischen Versorgung: ein Vergleich von HADS, GHQ-12 und Brief-
PHQ
Abstract
Objectives: The detection of patients with comorbid mental disorders
isofhighclinicalimportance.Screeninginstrumentscanberecommen-
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validity of the Hospital Anxiety and Depression Scale (HADS), General
HealthQuestionnaire(GHQ-12)andPatientHealthQuestionnaire(Brief-
PHQ-D) in chronically ill patients. 1 University of Northampton,
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Results: The Brief-PHQ and the HADS performed better than GHQ-12
concerningaffectiveandanxietydisorderswithoutreachingsignificance.
Health Services Research,
Freiburg University Medical
Centre, Freiburg, Germany Even though the Brief-PHQ performs significantly better in the category
of “any mental disorder”, the differences between the Brief-PHQ and
the HADS remain not significant considering anxiety and affective dis-
orders. The Brief-PHQ performed slightly better considering depressive
disorders with an area under the curve (AUC) of 0.844, a sensitivity of
80% and a specifity of 75.7%.
Conclusions:Screenercanbeusedforthedetectionofmentaldisorders
inpatientswithchronicalillness.EspeciallytheBrief-PHQandtheHADS
canberecommendedconsideringsensitivityandspecifity.Anadvantage
of the Brief-PHQ is the ability of categorial and dimensional analysis.
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Zusammenfassung
Zielsetzung: Das frühzeitige Erkennen komorbider psychischer Störun-
genbeiPatientenmitchronischenErkrankungenistvonhoherklinischer
Bedeutung. Screening-Instrumente können hierbei eine wichtige Hilfe-
stellung sein. Allerdings sollte bei der Auswahl der Instrumente beson-
deresAugenmerkaufdieValiditätfürdenjeweiligenIndikationsbereich
gelegt werden. Diese Studie vergleicht die Erkennensleistung der Hos-
pital Anxiety and Depression Scale (HADS), des General Health Ques-
tionnaire(GHQ-12)unddesPatientHealthQuestionnaire(Brief-PHQ-D)
aneinerStichprobevonPatientenmitchronischenkörperlichenErkran-
kungen.
Methodik:204PatientenausdermedizinischenRehabilitationnahmen
an einerzweistufigen Untersuchungteil : (1) Screeningmit HADS,GHQ-
12, Brief-PHQ und (2) diagnostisches Interview (M-CIDI). Die Validität
der Screeninginstrumente wurde anhand der ICD-10 Diagnosen aus
dem CIDI mittels ROC(receiver operating characteristics)-Analysen ver-
glichen.
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Research Article OPEN ACCESS Special issue: Diagnostic instrumentsErgebnisse: Es zeigte sich eine Überlegenheit des Brief-PHQs und der
HADS gegenüber dem GHQ im Erkennen von affektiven und Angststö-
rungen. Obwohl der Brief-PHQ signifikant besser in der Kategorie „ir-
gendeine psychische Störung“ abschneidet, bleiben die Unterschiede
zwischendemBrief-PHQundderHADSdieanderenBereichebetreffend
nicht signifikant.
Der Brief-PHQ zeigt eine etwas bessere Erkennensleistung hinsichtlich
affektiver Störungen mit einem AUC(area under the curve)-Wert von
0,844, einer Sensitivität von 80% und einer Spezifität von 75,7%.
Fazit:ScreenersindzumfrühzeitigemErkennenpsychischerStörungen
bei Patienten mit chronisch körperlichen Erkrankungen gut geeignet.
InsbesonderederBrief-PHQunddieHADSkönnenaufgrundihrerguten
Sensitivitäts- und Spezifitätswerten empfohlen werden. Ein Vorteil des
Brief-PHQ liegt in seiner Möglichkeit für die kategoriale und dimensio-
nale Auswertung.
Schlüsselwörter: Screening, chronische Erkrankung, psychische
Belastung, psychische Störung
Introduction
Over the past years mental disorders have received in-
creased attention in patients with chronic somatic di-
seases. Studies have shown that patients suffering from
chronic diseases have higher prevalence rates of mental
disorders than the general population without somatic
illness, with affective and anxiety disorders being most
common [1], [2], [3], [4], [5].
Itisofhighclinicalimportancetorecognizepsychological
symptoms, ranging from psychological burden or strain
to mental disorders or psychiatric illnesses that need
treatment,earlyandtointroducepsychologicalorpsychi-
atric intervention in time as to prevent (1) chronification
of disorders, (2) negative impact on coping skills and
decreaseofqualityoflifeaswellas(3)raisedhealthcare
costsduetoincreasedutilizationofmedicalservices[6],
[7],[8],[9],[10],[11],[12],[13],[14].Resultsconsidering
recognition of mental disorders in chronically ill rehabili-
tation patients though suggest, that there are problems
in the detection of mental disorders [13], [15]. Härter et
al.founddetectionratesforrehabilitationpatientsvarying
between 32%-48% [13], [15], whereas detection rates
in primary care are somewhat higher, ranging between
54%-74% [16], [17], [18], [19], [20], [21], [22]. Problems
in detecting mental disorders in somatically ill patients
can be explained by overlap of somatic and psychiatric
illnesses,atendencytounderestimatenegativeinfluence
of psychological symptoms in patients with somatic dis-
easesaswellasalackofknowledgeaboutpsychological
symptoms and syndromes.
Screening instruments can improve recognition rates of
mental strain and disorders while being time and cost
efficiently. These however must be tested considering
their validity for special groups of patients. Also it is im-
portant to trade off sensitivity and specifity due to the
needsoftheuser.Oneofthemostusedscreeninginstru-
ments is the Hospital Anxiety and Depression Scale
(HADS)[23].Thisscreenerhasbeenespeciallydeveloped
forandtestedinpatientswithsomaticdiseases.Another
well known and widespread screener is the General
Health Questionnaire in its twelve item version (GHQ-12)
[24]. It is designed as a self report instrument for the
measurementofglobalburdenduetodisease.Uptonow
ithasbeenusedinmanyepidemiologicalstudiesconcern-
ing mental disorders [25], [26], [27], [28], [29]. A rela-
tivelynewinstrumentisthePatientHealthQuestionnaire
(Brief-PHQ) [30], which has mainly been used in clinical
studies, even though there are not many international
studies using it up to now [31].
The discriminating validity of the HADS and GHQ-12 has
been tested by our group in patients with cancer, ortho-
paedicandcardiovasculardiseases[32],[33],[34],[35].
InthesestudiestheHADSperformedbetterinrecognizing
mental disorders than the GHQ-12 did. Nevertheless,
using the single scales of the HADS for the recognition
of anxiety and affective disorders did not bring any ad-
vantage compared to the overall performance [34].
The discriminating validity of Brief-PHQ and HADS in the
detection of depressive and anxiety disorders has been
tested so far in several clinical studies [36], [37], [38].
InallthesestudiestheBrief-PHQwassignificantlysuper-
ior to the HADS considering the detection of mental dis-
orders.
Uptonowacomparisonofdiscriminatingvaliditybetween
the three screeners HADS, GHQ-12 and Brief-PHQ for
patients with somatic diseases is missing. Because the
threeinstrumentsdifferconcerningtheirmethodological
conception(dimensionalvs.categoricalanddimensional
approach), were used in different settings until now
(clinical and epidemiologicalsettings) and have different
specifities (GHQ-12 raising global burden whereas Brief-
PHQ and HADS screening for anxiety and depression),
theaimofthisstudywastoinvestigatethediscriminating
validity of the HADS, GHQ-12 and Brief-PHQ in a larger
sample including the most frequent somatic diseases
(cancer, cardiology, orthopaedics, endocrinology and
pneumology). The analysis focused on the detection of
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disorders.Standardizedclinicalinterviewdiagnoseswere
the supposed criterion (gold standard) for validity of all
analyses.
Methods
Sample
The study sample was recruited from 13 rehabilitation
inpatientclinicsinsouth-westernGermanywithinalarger
epidemiological study investigating the prevalence of
mental disorders in chronically ill patients. The survey
was based on a two step procedure. All newly admitted
patients were consecutively tested using screeners
(HADS,GHQ-12andBrief-PHQ)aswellasotherselfreport
measures (e.g. quality of life – SF-36) first (step 1). This
happened within the first week of their stay at the clinic.
In a second step, a standardized clinical interview (CIDI)
was carried out by trained interviewers with randomly
selected patients as to gain the diagnoses according to
DSM-IV and ICD-10.
Measures
Hospital Anxiety and Depression Scale (HADS) [23]
TheHADSisaselfreportmeasurementtoassessanxiety
and depressive symptoms, consisting of two subscales
with each seven items (score 0-21). The items exclude
somaticsymptomsandthereforeavoidsymptomoverlap
between somatic illness and mood disorders. Good psy-
chometric values have been found for the HADS with in-
ternal consistency being 0.80 for both subscales and
retestreliabilityofr=0.81-0.89[39],[23].Sincenostudy
proves the achievement of the subscales to be superior
to the global score and the Brief-PHQ also has a total
score (when analyzed dimensional), for this analysis the
global 14-item total score is used.
General Health Questionnaire (GHQ-12) [24]
The GHQ-12 is a selfreport questionnairefor the assess-
ment of global burden due to diseases in non-psychiatric
settings.Itisofuseinidentifyinglevelsofseverityaswell
asto detectpsychiatriccasesin epidemiologicalstudies.
It consists out of 12 items with a score range of 0-12.
The psychometric values are good, with internal consist-
ency of 0.85 and retest reliability of r = 0.73 [40], [41].
Patient Health Questionnaire (Brief-PHQ) [30]
The Brief-PHQ has been developed from the PRIME-MD
System for diagnosing mental disorders. It consists of
twosubscales:onefortheassessmentofpanicdisorders
and one for affective disorders. Additionally information
about psychosocial functioning is raised. The Brief-PHQ
can be used for dimensional as well as categorical diag-
nostics. Using it as a dimensional instrument, scores
between 0 and 27 are possible. Psychometric values
have been found to be good [30]. In this study the Brief-
PHQ is used as a dimensional instrument as to be able
to compare it to the other screeners.
Composite International Diagnostical Interview (M-CIDI)
[42]
The M-CIDI is and expanded, updated and computerized
version of the World Health Organization CIDI [43]. It
provides reliable and efficient assessment of symptoms,
syndromes and diagnoses of 48 psychiatric disorders
(current,pastyearandlifetimeprevalences).Furthermore
it provides information about age of onset as well as
duration and severity of symptoms. Several studies
examining the psychometrics of the CIDI found satisfac-
tory validity, with interrater reliability of kappa = 0.82-
0.98 [42], [43], [44].
Data analysis
Receiver operating characteristics (ROC) analysis was
used to analyse the diagnostic accuracy of the three
screener HADS, GHQ-12 and Brief-PHQ in comparison to
the diagnoses achieved with the standardized clinical
interview CIDI.
InaROCcurvethetruepositiverate(Sensitivity)isplotted
in function of the false positive rate (100-Specificity) for
different cut-off points of a parameter. Sensitivity is the
probability that a test result will be positive when the
disease is present (true positive rate, expressed as a
percentage).Specifityontheotherhandistheprobability
that a test result will be negative when the disease is not
present (true negative rate, expressed as a percentage).
The area under the ROC curve (AUC) is a measure of how
wella parameter candistinguishbetweentwo diagnostic
groups (diseased/healthy). Values range between 0.5
(no discriminatory ability) to 1.0 (perfect discriminatory
ability). Each point on the ROC plot represents a sensitiv-
ity/specificity pair corresponding to a particular decision
threshold, in this case cut-offs of the screener. The
probability, that the test is positive, when the disease is
present,iscalledthepositivepredictivevalue(PPV).Three
ROCanalyseswereperformed.Thepsychiatricdiagnoses
from the CIDI (current 4-week prevalence) were used as
case definition (criterion). The first analysis used all pa-
tients with any mental disorder as criterion. The second
analysis focuses on patients with current affective dis-
orders(majordepression,dysthymiaetc.)andinthethird
analysis patients with anxiety disorders were referred as
cases (panic disorder, simple phobias etc.).
TheROCcurvesforeachdiagnosticgroupandthecorres-
ponding AUC were compared. According to findings that
question the validity of the two HADS subscales the
global score (0-42) was used. The cut-off points that
minimize false positive and false negative tests will be
reportedaswellasthecorrespondingsensitivity,specifity,
positive and negative predictive value (PPV and NPV).
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Results
Patients
A total of 204 patients participated in the two-stage
examination. The mean age was 49.6 (range: 18-80),
withamale/femaleratioof52%to48%(Table1).Somat-
ically, 5.9% were suffering from cardiovascular diseases,
8.8%fromorthopaedicdiseases,5.4%hadcancer,18.6%
an endocrinologic disease and 53.4% had a pneumolo-
gical disease (due to the fact, that pneumological dis-
eases were the focus of the study). 7.8% of the patients
had other somatic diseases. 28.8% of the patients re-
ceived a diagnosis for a mental disorder corresponding
to DSM-IV (4 weeks prevalence), 17.2% had an affective
disorder and 7.8% an anxiety disorder.
Receiver operating characteristics
analyses (ROC)
For the analysis of sensitivity, specifity and positive pre-
dictive value (PPV) patients with a current psychiatric
diagnosis(N=59)weredividedintogroupsof(a)patients
with affective disorders (N=35) and (b) patients with
anxiety disorders (N=16).
The mean scores of HADS, Brief-PHQ and GHQ-12 were
significantly higher in patients with a current psychiatric
diagnosis compared to patients with no mental disorder
(p<0.001; ANOVA) (Table 2). Additionally patients with
affective and anxiety disorders differ significantly from
patients without these disorders (p<0.000; ANOVA).
Figures1-3reporttheabilityofthethreescreenersHADS,
Brief-PHQandGHQ-12toidentifypatientswithanymental
disorders (Figure 1), affective disorders (Figure 2) and
anxietydisorders(Figure3)correctly.Theoverallaccuracy
(AUC) of the HADS and Brief-PHQ in detecting patients
with any mental disorder differs markedly from the
GHQ-12, with only the Brief-PHQ reaching significance
level (pPHQ/GHQ-12=0.038, pPHQ/HADS=0.871, test for equalities
of area).
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detection of any mental disorder
Figure2:ReceiverOperatingCharacteristics(ROC)for affective
disorders
Figure 3: Receiver Operating Characteristics (ROC) for anxiety
disorders
Also, the ROC-analysis for the detection of affective dis-
orders (Figure 2) shows, that the AUC of the Brief-PHQ
surpassestheAUCsoftheHADSandtheGHQ-12,without
reaching significant level though (pPHQ/HADS=0.197, pPHQ/GHQ-
12=0.149, test for equalities of area). Corresponding re-
sults were found for the ability of the three screeners in
detecting anxiety disorders. Again, the Brief-PHQ-curve
exceedsthecurvesoftheHADSandtheGHQ-12,without
reachingsignificantlevelsthough(pPHQ/HADS=0.797, pPHQ/GHQ-
12=0.223, test for equalities of area).
Table 3 reports the best balanced cut-offs for the three
screeners along to the results considering sensitivity,
specifity as well as positive predictive values (PPV) and
negative predictive values (NPV). As to make sure that
anymentaldisorderoranaffectivedisorderisrecognised
with the HADS, a cut-off of 18 should be chosen (HADS-
totalscore).Fortherecognitionofpatientswithananxiety
disorder, the cut-off should be 20 considering the HADS-
total score. The highest positive predictive value (PPV)
was found for the HADS in recognizing any mental dis-
order (61.8%).
Considering the Brief-PHQ, the best cut-off points varied
between 11 (recognition of affective disorders) and 15
(recognitionofanymentaldisorder).Astoidentifypatients
with an anxiety disorder, a cut-off of 12 is best being
chosen. Compared to the HADS and the GHQ-12, the
Brief-PHQ has the best results in recognising any mental
disorder, meaning that in 81.6% of all cases the Brief-
PHQ is able to identify patients with any mental disorder
correctly (PPV). Since the Brief-PHQ can either be used
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ascategoricalorasdimensionalinstrument,additionally
itsabilityinidentifyingpatientswithaffectiveandanxiety
disorders were checked concerning categorical analysis.
Goodsensitivityandspecifityvalueswerefoundinrecog-
nizing major depression (sensitivity: 78%, specifity: 81%,
PPV: 29%), whereas the Brief-PHQ showed to have prob-
lems to identify patients with panic disorders in this
sample (sensitivity: 33%, specifity: 90%, PPV 13%).
Using the GHQ-12 for the identification of patients with
any mental disorder, an affective or an anxiety disorder,
a cut-off of 7 can be recommended.
Sensitivity of the screeners differ somewhat at their best
cut-off points, according to diagnostic group (Table 3).
Sensitivity score for recognition of any mental disorder is
betterintheHADSthanintheGHQ-12andtheBrief-PHQ
(71.2% vs. 69.5 vs. 55.5%). Nevertheless, the positive
predictive value for the Brief-PHQ is clearly better than
of the HADS and GHQ-12 (81.6% vs. 61.8% vs. 51.9%),
meaning a higher probability of a positive test result in
the Brief-PHQ than in the two other screeners, in case
any mental disorder is present.
The Brief-PHQ has a higher sensitivity for recognizing af-
fective disorders (80%) than the GHQ-12 (77.1%) which
is surpassing sensitivity of the HADS (71.4%). Also the
positivepredictivevaluescoresclearlyhigherintheBrief-
PHQ than in the HADS and GHQ-12 (40.6% vs. 36.8% vs.
34.2%). In identifying anxiety disorders, the Brief-PHQ
and GHQ-12 scores of sensitivity is equally 81.3%,
whereas the Brief-PHQ has a somewhat higher positive
predictivevaluethantheGHQ-12(21.0%vs.16.5%).That
means that it is more likely that the Brief-PHQ shows a
positive result in patients that really do suffer from an
anxietydisorder.Concerningspecifity,thustheprobability
of recognizing patients without any disorder and without
affectivedisorder,theBrief-PHQsurpassestheHADSand
theGHQ-12(95.2%vs.82.1%vs.73.8%,resp.75.7%vs.
74.6% vs. 69.2%). Only in identifying patients who are
not suffering from an anxiety disorder, the HADS sur-
passes the Brief-PHQ slightly and the GHQ-12 clearly
(specifity: 78.7% vs. 73.9% vs. 64.9%). Misclassification
ratesoftheinstrumentsvary between21.0% (Brief-PHQ)
and 42.0% (GHQ-12).
Discussion
This article describes the validation of three screeners,
the HADS, Brief-PHQ and GHQ-12 for a population of
chronically ill patients using ROC analysis. All patients
were taken from rehabilitation inpatient clinics in the
south-west of Germany. Indications of the sample were
cardiology, orthopedics, oncology, endocrinology and
pneumology. Patients with a pneumologic disease made
out the biggest part of the sample due to study plan. As
a gold standard for the ROC analyses the diagnoses of a
standardized clinical interview (M-CIDI) were chosen.
Theresultsaresimilartoearlierfindingsofourgroupwith
theHADSclearlysurpassingtheGHQ-12indiscriminating
patients with and without mental disorders. That is the
caseforallofourchosencriteria,meaningtherecognition
of patients with (1) any mental disorder, patients with (2)
an affective disorder and patients with (3) an anxiety
disorder. The Brief-PHQ significantly surpasses the
GHQ-12 in recognising any mental disorder and also the
HADS, even in this case results do not reach significance
level. Sensitivity and specifity is levelled out in a good
manner for all screeners, meaning that the proportion of
correctly-positiveandcorrectly-negativeassignedpatients
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considering recognition of any mental disorder and the
performance of the GHQ-12 in the recognition of anxiety
disorders.
Comparably to the study of Gräfe et al. [45] very good
sensitivityandspecifityvaluesarefoundfortheBrief-PHQ
when evaluated categorically.
Best cut-offs were calculated for every screener. For the
HADS, the best cut-off point is 18 for identifying any
mentaldisorderoranaffectivedisorderand20forrecog-
nizing patients with an anxiety disorder. For the GHQ-12
a cut-off of 7 was found to be best for all our chosen
groups. The best cut-off points for the Brief-PHQ vary
between 11 (recognition of affective disorders) and 15
(recognitionofanymentaldisorder;12fortherecognition
of anxiety disorder) and therewith the Brief-PHQ being
less consistent than the HADS and the GHQ-12 in this
population. This variation of cut-offs in the Brief-PHQ
makes the handling of the instruments when used for
differentsettingscomplicated.Thismightbeanimportant
factorthatneedstobelookedatwhenchoosingtheBrief-
PHQ.
The results of this study need to be viewed with some
restrictions. First of all, the sample of this study is not
homogenous, meaning that there is a strong overlap of
patients with pneumologic disorders. That is due to the
studyplan,studyingprevalenceratesofmentaldisorders
in patients with pneumologic and endocrinologic dis-
orders. Also the chosen criteria for diagnosis of mental
disorders were quite strict, excluding for instance sub-
threshold disorders as well as adjustment disorders.
Subthresholddisordersmightnotbefoundwithscreeners
that have been developed as categorical or assessment
tools. Moreover the used screeners were analysed in a
dimensionalway,whereasmentaldiagnosesarecategor-
ical. This is an important methodological limitation of di-
mensionally interpreted screeners. The Brief-PHQ, which
proved to be better than the HADS and GHQ-12 in this
study, can also be analyzed categorical, which again is
an important advantage of this instrument. Also in this
study we chose to look at unspecific criteria by referring
to“anymentaldisorder”,whichmightexplaintheperform-
ance of the HADS, which performs best under genuine
screeningcriteria.Byexamingthesinglescales,different
results might have shown up. Another methodological
limitation is the fact that due to the small sample size
age and sex could not be controlled. Also it should be
kept in mind, that the GHQ, other than the two other
screeners, has not been created for the detection of
mental disorders and their screening. This might explain
the advantages of the HADS and the PHQ in this study.
Nevertheless is this study the first to our knowledge that
compared performances of the HADS, GHQ-12 and the
Brief-PHQ in a sample of somatic ill patients. The results
show that the Brief-PHQ as well as the HADS can be re-
commended as efficient instruments to detect mental
disorders in somatically ill patients.
Conclusion
Taking into account the negative effects that unrecog-
nized mental disorders have on chronical illness and the
health care system, screening instruments should be
used as a routine in the treatment of somatically ill pa-
tients.Thiswayadditionalpsychologicalassessmentand
psychologicaltreatment(whereneeded)canbeassigned
before personal and socially negative effects become
worse.
Notes
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